NCT05165589

Brief Summary

To assess the ability of a machine learning algorithm to accurately detect fussing and crying time in infants using accelerometery data collected from a wearable device, compared to the Barr's parent-/caregiver-completed behaviour diary.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 15, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

October 15, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 21, 2021

Completed
11 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2022

Completed
Last Updated

December 21, 2021

Status Verified

December 1, 2021

Enrollment Period

3 months

First QC Date

October 15, 2021

Last Update Submit

December 14, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Device feasibility: Comparison of device-generated versus diary-reported crying and fussing time data

    Part 1: Comparison of daily crying and fussing time data generated by accelerometer and machine-learning versus crying and fussing time data reported by parental Barrs diary

    4 days

  • Device feasibility: Comparison of device-generated versus diary-reported crying and fussing time data

    Part 2: Comparison of daily crying and fussing time data generated by accelerometer and machine-learning versus crying and fussing time data reported by parental Barrs diary

    7 days

Secondary Outcomes (3)

  • Device feasibility: Comparison of device-generated versus diary-reported crying time data

    7 days

  • Device feasibility: Comparison of device-generated versus diary-reported fussing time data

    7 days

  • Device feasibility: Comparison of device-generated versus diary-reported sleeping time data

    7 days

Study Arms (2)

Part 1: Initial data collection for device feasibility

EXPERIMENTAL

3 subjects for 4 days included to collect initial data for algoritm development for device feasibility

Device: ActiveInsights accelerometer device

Part 2: Device feasibility

EXPERIMENTAL

10 subjects for 7 days included to evaluate device feasibility

Device: ActiveInsights accelerometer device

Interventions

Accelerometer device

Part 1: Initial data collection for device feasibilityPart 2: Device feasibility

Eligibility Criteria

Age4 Weeks - 12 Weeks
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Aged between 4-12 weeks at screening.
  • Gestational age 37 weeks - 41 weeks at birth.
  • Birth weight appropriate for gestational age (AGA - weight between 10th and 90th percentile) or Large for Gestational Age (LGA - weight above the 90th percentile) determined using WHO Weight-for Age percentile guides.
  • Infant has excessive crying, defined as 3 or more hours per day, during 3 or more days in the preceding week.
  • No birth trauma and nonsyndromic.
  • Readiness and the opportunity for parents/caregivers to fill out a study diary, questionnaires and for infant to wear device.
  • Parent/caregiver with ability to understand and comply with the requirements of the study, as judged by the Investigator.
  • Parent/caregiver willing and able to give informed consent for their and their infant's participation in the study.
  • Infant is considered healthy, following physical exam.

You may not qualify if:

  • Infants with failure to thrive, intrauterine growth retardation, haematochezia (blood in the stools), diarrhoea (watery stools that takes the shape of a container \> 12x in breastfed and \>5 in partially breastfed infants daily), or fever (38.0 degrees).
  • Premature infants (\<35 weeks gestation at birth).
  • Infants with congenital heart disease, immunodeficiency, asplenia, cancer, cystic fibrosis, formula-fed infants, and those with liver disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Atlantia Clinical Trials

Cork, Ireland

RECRUITING

MeSH Terms

Conditions

Infant Behavior

Condition Hierarchy (Ancestors)

Child BehaviorBehavior

Central Study Contacts

Gianfranco Grompone, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
SINGLE GROUP
Model Details: Part 1: 3 subjects for 4 days included to collect initial data for algoritm development for device feasibility evaluation Part 2: 10 subjects for 7 days included to evaluate device feasibility
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 15, 2021

First Posted

December 21, 2021

Study Start

October 15, 2021

Primary Completion

January 1, 2022

Study Completion

April 1, 2022

Last Updated

December 21, 2021

Record last verified: 2021-12

Data Sharing

IPD Sharing
Will not share

Locations